Christophe Berthoux, MD
Chairman
Biotech and Pharma Drug Development Strategy
Christophe is IAG's Chairman. He spent his 20+ year career within the Clinical Research industry, and brings extensive expertise and knowdledge of this sector. Christophe was CEO of UK based Synexus, a leading global SMO and European CEO of Citoxlab
Christophe Berthoux, is a doctor in veterinary medicine and holds an MBA from Purdue University, Indiana (US). Currently, he is an Operating Parter in ArchiMed, independent investment firm specialized in the Healthcare industries and CEO of NAMSA.
IAG, Image Analysis Group
Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.
Image Management Platform
Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.
Careers
In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.